We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Sareum Holdings Plc | SAR | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 5.00 | 14.29% | 40.00 | 15:43:26 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 35.00 | 35.00 | 40.50 | 40.00 | 35.00 |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
| Top Posts |
|---|
Posted at 26/5/2024 21:00 by wolfoffoolstreets No worries. I’m not aiming to silence you……And then when you slagged off Sareum Investors for poor spelling followed by copious posts with your bad spelling and grammar. Whilst your here, I’ll be here 😊 |
Posted at 22/5/2024 16:16 by wolfofwallstreets I literally cannot wait for sareum to crash to 0...An incompetent bod coupled with happy clsppy sucker investors... Sareum will never "come good".. And I can't wait to see the downfall... |
Posted at 29/4/2024 17:16 by peaceandlove It's all "ifs, buts and maybes" over at LSE. The share price got to 38p last Wednesday. I repeatly stated it was a pump and dump. The smart investors sold and moved on. You can see the herd has left for pastures new. The not so smart investors (LTH's) are still invested spouting nonsense about £300million here a £billion there LOL particularly SOG who stated earlier today, he felt the share price will reach 45p-50p by the end of the week. A 100% rise from now. Wishful thinking SOG. Perhaps another break for you me thinks.Saftey data for 1801 will give the share price a shot in the name - that's all - maybe reach 50p if lucky before a falling back. People forget 1801 has not be proven to work as of yet. Did you see the link I put up earlier today. TM was talking up licensing deals in June 2020. Sareum Holdings remains a massive gamble. I personally do not feel they'll ever licence their products. All talk and no action. |
Posted at 26/4/2024 09:36 by horridhenry What really sets the mong apart from others stupid enough to respond to him (me), is that he is much more bothered than any of us, and the longer he continues the more stupid he lookshe doesn't differentiate between long term investors confident in their situation and want to talk about it, and others that come and go for a quick profit being confident in your investment is not ramping, and no new investor will put money in based on the posting of long term holders. Peace/Pete/Wolf you are an obsessed Mong. |
Posted at 09/4/2024 22:08 by criticalthinker1 Very on point by the investor on lse who has posted 3 times in 13 years!Twice this evening! They imo are obviously aware of the very poor decisions that have been made when given the recent fundraiser this could have been done when we were at £2.50 ish. This is more than mismanagement by poor decision making acumen given the vitriol we are served about the cvs of appointed individuals to guide the scientific individuals...this is a British company researching drugs for the betterment of society backed by small private investors who have not only been bent over...but the affiliation with CRUK comes into play. Let's not hope this reaches the papers like Sirius Minerals and the marketing they did to get the locals involved which effectively sold out to Anglo American with deep ties to Qatar and the reserves of potash that will be destined to re green elsewhere apart from our green and pleasant land...which is and will be a very similar story that garners attention such as the Post Office/Fujitsu/Horiz Just imagine if a hit job was undertaken on a promising drug development company but it was put on a few years project by a larger pharma with certain assistance to divide the support and hope people forgot...and then it got 'rescued'. EGM NEEDED ASAP. |
Posted at 30/3/2024 22:24 by peaceandlove I honestly think the MHRA didn't authorise Sareum's clinical trial because they felt that the novel formulation isn't a sufficient innovation to expose fit and healthy volunteer-patients to the risks of the trial. In addition, if anyone noticed at the time, Sareum's website stated "the company admits that to go forward through and beyond the Phase 1 trial, it will have to go back to investors to raise more money". This is why I wouldn't trust SOG and Co as far as I could throw them. The happy clappers only state the points that favour Sareum. Not once have they uploaded evidence that Sareum's products are ahead of competitors. SOG and all the happy clappers are small time investors that have gambled their money into a small bio hoping and actually convincing themselves that they're going to be rich. Wolf, they're of their nuts 😆🤣 All of them talk more nonsense than David Icke 😆Seriously, you mark this post when I say I told you so. Unfortunately, more people will invest their hard working money into this company hoping that this is the right one, I'm afraid in my honest opinion this won't come true. However, I expect they'll carry on ramping to the bitter end. Absolute madness!!!!!! Ignore CS, he's on the special brew again. Poor fella. Happy Easter 🐣 |
Posted at 16/3/2024 19:51 by criticalthinker1 OK Wolf. That's a fair shout.But I think it is only fair that investors understand the individuals that Sareum investors are paying for to represent us. I suggest all investors do their own due diligence on the employees of Peel Hunt (and affiliates)and if they feel they have appropriate skill sets. Check it out on LinkedIn Ella Hastings Benjamin Harris Matt Hoole Anup Das Rob Parker Edward Lowe Tom Graham Find Nugent Paul Shackleton Josh Harvey Plenty more I can post but it all stems back to Mr Steel and a certain Mr Parkers affiliations with a previous Peel Hunt employee! Are they worth your SIPPS security? Are they worth our fee? Are they worth our IR dealings? Do they work for the lowly shareholders or someone else. More I can say and blow this right open. Opportunity for the board to step up. |
Posted at 16/3/2024 14:51 by peaceandlove What I see is a man that doesn't won't to admit defeat. Sad, is a firm believer that whatever the dilution and cost to the shareholders, 1801 will come good and Sareum will license etc etc. I just can't see that at this stage.Some of the LSE posters get it, but unfortunately him and over 50% of others are emotionally invested in this company stock. Sar was their answer to giving up work, paying of the mortgage, parties on yachts etc. It's a pipe dream. Very Sad to be honest. I have an element of sympathy for the investors that were encouraged by SOG, Mr Rerate etc. I expect some of them will need psychological support. They need to get their head around why the share price is at 20 odd pence and quick before losing it all. I've seen this many times over the last 20 years. We're always chasing the life changing amount on Aim including me, the problem is only 5% of investors will ever hit the big time of a penny share hitting above a £1. |
Posted at 15/3/2024 09:35 by peaceandlove I know Wolf. Didn't notice until their first reply. I expect it's one of the LSE happy clapper brigade.Nothing has changed. Honestly, I feel the share price will be in single digits very soon. Once that happens the fool will disappear. SOG on LSE trying to justify why Sareum is still a great investment. I actually feel for the guy. Been invested for over 10 years and look where they are. These type of investors crack me up TBH. They seem to think they'll make life changing money from investing in one Aim stock. It just doesn't work like that. Okay 1% may hit the jackpot, but the remaining 99% do not. Unbelievable emotional investors. They'll lose everything. The truth hurts I get it. But once again there is no more money. Without funds the company cannot continue. It'll be very interesting to see if they can raise funds, The share price would definitely fall below 1p. |
Posted at 12/3/2024 18:21 by criticalthinker1 4th Feb 2022 from Sareum BODSSareum Holdings PLC - Cambridge, England-based drug developer for cancer and autoimmune diseases - Calls extraordinary general meeting for February 28 to approve a 50-into-1 share consolidation. Sareum says its current large number of shares, at 3.40 billion, and low share price create a negative perception among investors. Reducing the number of shares by a factor of 50 will increase the share price and make the stock "more attractive to a broader range of investors", it says. So they decided after apointing Peel Hunt on 29.10.21 that an EGM wad the way forward no doubt on advice from Peel Hunt who we pay! So it is not disproportionate to ask for an EGM from the shareholders is it!? And note if you draw the line on the share price from when Peel Hunt joined it is a direct descent and VERY questionable abilities provided ...so what do they do? We have bolstered our IPR and 737 back 'somewhere'. Still heard no one on lse pick up on my point re where trials take place because we got screwed last time. If they have screwed that then definitely corruption is apparent. We could have raised before around 2.50 But silence on that And plenty more we will look into but don't forget a poster on lse lauded a chap at the last meeting as the introducer. Well what happens to their (at the time) 29000000 shares at exercise price of 5p (at the time) executable by 31.5.26. Like I say more to dovetail re MAERS and NOMAD responsibilities but will get appropriation of who is not doing their job. Which entails fines and possible dismemberment of providing services or acting as a director for x time All best Steadydanny |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
